Evidence map›Paper›PMID 40004707›Full record

ArticleJournal of clinical medicine2025

The Expression Level of SOX Family Transcription Factors' mRNA as a Diagnostic Marker for Osteoarthritis.

Kamila Baran, Ewa Brzeziańska-Lasota, Jakub Kryczka, Joanna Boncela, Aleksandra Czechowska, Karolina Kopacz, Gianluca Padula, Krzysztof Nowak, Marcin Domżalski

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kamila BaranDepartment of Biomedicine and Genetics, Chair of Biology and Medical Microbiology, Medical University of Lodz, 92-215 Lodz, Poland.ORCID 0000-0002-0029-9706
Ewa Brzeziańska-LasotaDepartment of Biomedicine and Genetics, Chair of Biology and Medical Microbiology, Medical University of Lodz, 92-215 Lodz, Poland.ORCID 0000-0002-0882-1458
Jakub KryczkaInstitute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.ORCID 0000-0002-5719-4139
Joanna BoncelaInstitute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.ORCID 0000-0001-8419-7012
Aleksandra CzechowskaAcademic Laboratory of Movement and Human Physical Performance, Medical University of Lodz, 90-001 Lodz, Poland.ORCID 0000-0003-0321-9836
Karolina KopaczAcademic Laboratory of Movement and Human Physical Performance, Medical University of Lodz, 90-001 Lodz, Poland.ORCID 0000-0002-4156-6030
Gianluca PadulaAcademic Laboratory of Movement and Human Physical Performance, Medical University of Lodz, 90-001 Lodz, Poland.ORCID 0000-0002-2748-9681
Krzysztof NowakDepartment of Orthopedics and Traumatology, University Clinical Hospital No. 2 of the Medical University of Lodz, 90-549 Lodz, Poland.
Marcin DomżalskiDepartment of Orthopedics and Traumatology, University Clinical Hospital No. 2 of the Medical University of Lodz, 90-549 Lodz, Poland.

Funding

Department of Orthopedics and Traumatology of the University Clinical Hospital No. 2 of the Medical University of Lodz Statut No. 503-11-001- 1-040-01Medical University of Lodz Statute No. 503/1-013-02/503-11-003National Centre for Research and Development grant No. POWR.03.02.00-00-IO12/16
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

osteoarthritisprognosis biomarkerreal-time polymerase chain reactionSOX family transcription factors

Identifiers

PMID40004707
PMCPMC11856735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.